# Cross-Pollination Manifest: NSE â†’ PS

> **Barrier:** 1
> **Source Pipeline:** NASA Systems Engineering (NSE)
> **Target Pipeline:** Problem-Solving (PS)
> **Created:** 2026-01-31T21:30:00Z
> **Status:** COMPLETE

---

## Purpose

This manifest lists all NASA Systems Engineering pipeline artifacts from Phase 0 that are being shared with the Problem-Solving pipeline for use in Phase 1 and beyond.

**Downstream PS agents MUST read these artifacts** to ensure informed analysis, investigation, and research based on comprehensive systems engineering findings.

---

## Artifacts for Cross-Pollination

### Tier 1a: Exploration & Requirements

| # | Artifact | Path | Description | Phase 1 Consumer |
|---|----------|------|-------------|------------------|
| 1 | Divergent Alternatives | `nse/phase-0/nse-explorer/divergent-alternatives.md` | 60+ options explored across 6 categories: repository structure, CLAUDE.md decomposition, documentation organization, work tracker extraction, migration paths, community engagement. NASA SE trade study format. | ps-researcher (deep dive), ps-analyst (trade-off analysis) |
| 2 | Current State Inventory | `nse/phase-0/nse-requirements/current-state-inventory.md` | 27 gaps identified. Shall-statement format. Token counts for CLAUDE.md sections. Skills completeness assessment. Template compliance status. | ps-analyst (gap analysis), ps-investigator (problem scope) |

### Tier 2: Risk Identification

| # | Artifact | Path | Description | Phase 1 Consumer |
|---|----------|------|-------------|------------------|
| 3 | Phase 0 Risk Register | `risks/phase-0-risk-register.md` | 21 risks identified using NASA 5x5 matrix. 2 CRITICAL (LICENSE, credentials), 5 HIGH, 9 MEDIUM, 5 LOW. FMEA analysis completed. Treatment sequence defined. | ps-analyst (risk-informed analysis), ps-investigator (risk investigation) |

### Shared Artifacts (Both Pipelines)

| # | Artifact | Path | Description | Phase 1 Consumer |
|---|----------|------|-------------|------------------|
| 4 | QG-0 NASA QA Audit v2 | `quality-gates/qg-0/nse-qa-audit-v2.md` | NASA NPR-7123.1D compliance audit. Score: 0.941. Artifact validation, traceability verification, process compliance. | All Phase 1 agents (quality baseline) |
| 5 | Phase 0 NSE Status Report | `reports/phase-0/nse-status-report.md` | SE status: 68% OSS readiness, 100% NPR compliance, 12 artifacts, L0/L1/L2 coverage. | ps-reporter (status continuity) |

---

## Key Findings Summary (for PS Pipeline Consumption)

### Divergent Alternatives Explored (nse-explorer)

| Category | Options Explored | Recommended | Rationale |
|----------|------------------|-------------|-----------|
| Repository Structure | Monorepo, Multi-repo, Dual-repo, Fork-based | Dual-repo (source-repository internal, jerry public) | Balance IP protection with community engagement |
| CLAUDE.md Decomposition | Monolithic, Import-based, Skill-referenced, Hybrid | Hybrid (core + imports + skill references) | Context rot mitigation while maintaining coherence |
| Documentation | Monolithic, Multi-file, Generated, Wiki-based | Multi-file with generated index | Scalability with navigation |
| Work Tracker | Embedded, Skill-extracted, External tool | Skill-extracted | Separation of concerns |
| Migration | Big bang, Incremental, Feature-flagged | Incremental with feature flags | Risk mitigation |
| Community | Discord, Discussions, Both, Forum | GitHub Discussions + Discord | Modern OSS pattern |

### Current State Inventory Summary (nse-requirements)

| Component | Status | Gap Count | Priority |
|-----------|--------|-----------|----------|
| CLAUDE.md | EXISTS (912 lines) | 3 gaps | HIGH (over-sized) |
| LICENSE | MISSING | 1 gap | CRITICAL |
| SECURITY.md | MISSING | 1 gap | HIGH |
| Skills | 5 exist | 4 gaps | MEDIUM |
| Tests | 2,530 exist | 2 gaps | LOW |
| Documentation | Partial | 16 gaps | MEDIUM |

### Risk Register Summary (nse-risk)

| Severity | Count | Examples |
|----------|-------|----------|
| CRITICAL | 2 | Missing LICENSE, credential exposure |
| HIGH | 5 | Missing SECURITY.md, CLAUDE.md bloat, dual-repo sync |
| MEDIUM | 9 | PyPI availability, templates, Dependabot |
| LOW | 5 | Graveyard cleanup, minor docs |

---

## Usage Instructions for PS Agents

### ps-researcher (Phase 1 - Deep Dive)
```
MANDATORY READS:
1. nse/phase-0/nse-explorer/divergent-alternatives.md (prioritize research areas)
2. risks/phase-0-risk-register.md (risk-informed research)
3. quality-gates/qg-0/nse-qa-audit-v2.md (quality findings)

FOCUS AREAS (derived from NSE findings):
- Decomposition with imports pattern (detailed implementation)
- Multi-persona documentation authoring (L0/L1/L2 guidelines)
- OSS repository structure best practices (dual-repo pattern)
```

### ps-analyst (Phase 1 - Gap Analysis, FMEA, 5 Whys)
```
MANDATORY READS:
1. nse/phase-0/nse-requirements/current-state-inventory.md (27 gaps to analyze)
2. risks/phase-0-risk-register.md (21 risks for FMEA input)
3. nse/phase-0/nse-explorer/divergent-alternatives.md (trade-off context)

FRAMEWORKS TO APPLY:
- 5W2H on each gap (Who, What, When, Where, Why, How, How Much)
- Ishikawa (Fishbone) for root cause categorization
- FMEA for failure mode analysis
- 8D for problem resolution
- Pareto (80/20) for prioritization
```

### ps-investigator (Phase 1 - Problem Investigation)
```
MANDATORY READS:
1. nse/phase-0/nse-requirements/current-state-inventory.md (problem scope)
2. risks/phase-0-risk-register.md (risk context)

INVESTIGATION TARGETS (from NSE findings):
- Transcript skill output inconsistency (Sonnet vs Opus) - ACT-010, ACT-011
- CLAUDE.md maintainability issues
- Work tracker skill incompleteness
```

---

## Traceability

| Source | Destination | Verification |
|--------|-------------|--------------|
| Phase 0 NSE artifacts | Phase 1 PS agents | Agents must cite this manifest |
| 27 gaps identified | ps-analyst gap analysis | All gaps must be addressed |
| 21 risks identified | ps-analyst FMEA | All risks must be analyzed |
| Divergent alternatives | ps-researcher deep dive | Recommended paths must be researched |

---

*Cross-pollination complete. PS pipeline has full access to NSE Phase 0 findings.*
*Document ID: PROJ-009-ORCH-B1-NSE2PS*
